摘要
循证中医药学是循证医学中国化发展的创新成果之一。目前循证中医药学发展已取得了阶段性成绩:基于证据的科学决策模式深入人心;创建了系列中医药循证评价研究关键技术;制定了与国际接轨的技术规范;建立了中医药临床研究证据库;在国际知名期刊发表了一批高质量临床研究;循证中医药学国际论坛成为品牌。循证中医药学发展的困难主要包括:证据基础薄弱、证据产出困难和研究力量分散。基于中医药学发展的机遇和挑战,本文提出了未来循证中医药学发展的近期和远期目标、实施路径、五大重点方向,并提出了三条推进循证中医药深化发展的建议。
Evidence-based Chinese medicine(EBCM) is one of the innovative achievements in the development of evidence-based medicine(EBM) in China. The EBCM has made initial progress: the evidence-based scientific decisionmaking model has become popular;a series of key technologies for evidence-based evaluation and research of traditional Chinese medicine(TCM) have been established;several technical specifications have been formulated in line with international standards;clinical evidence database of TCM has been established;a number of high quality clinical trials have been published in internationally renowned journals;and the International Forum on Evidence based Chinese Medicine(EBCM) has become a brand conference. Difficulties in EBCM development mainly involve: lack of high quality clinical evidence, difficulty in producing evidence, and decentralization of research team. Based on opportunities and challenges of the development of TCM, this article proposed the short-term and long-term goals, implementation paths and five key directions for the development of EBCM in the future, and puts forward three suggestions for further development of EBCM.
作者
张俊华
孙鑫
李幼平
张伯礼
ZHANG Junhua;SUN Xin;LI Youping;ZHANG Boli(Evidence-Based Medicine Centre,Tianjin University of Traditional Chinese Medicine,Tianjin,301617,P.R.China;Chinese Evidence-Based Medicine Centre,West China Hospital,Sichuan University,Chengdu,610041,P.R.China)
出处
《中国循证医学杂志》
CSCD
北大核心
2019年第5期515-520,共6页
Chinese Journal of Evidence-based Medicine
基金
国家自然科学基金项目(编号:81473544)
天津市人才发展特殊支持计划-青年拔尖人才项目(编号:201504)